๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Influence of proteasome inhibitor bortezomib on the expression of multidrug resistance genes and Akt kinase activity

โœ Scribed by L. A. Panischeva; E. S. Kakpakova; E. Y. Rybalkina; A. A. Stavrovskaya


Book ID
110155622
Publisher
Springer
Year
2011
Tongue
English
Weight
469 KB
Volume
76
Category
Article
ISSN
0006-2979

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Antitumor activity of the selective epid
โœ Ichiro Naruse; Tohru Ohmori; Yoko Ao; Hisao Fukumoto; Toshio Kuroki; Masatomo Mo ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 216 KB ๐Ÿ‘ 1 views

## Abstract Selective tyrosine kinase inhibitors are regarded as promising antitumor agents for cancer treatment. Iressaยฎ (ZD1839) is an orally active, selective EGFRโ€TKI (epidermal growth factor receptorโ€tyrosine kinase inhibitor) that blocks signal transduction pathways implicated in cancer cell

Influence of the tyrosine kinase inhibit
โœ Kristin Lรถber; Amparo Alfonso; Luis Escribano; Luis M. Botana ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 363 KB ๐Ÿ‘ 1 views

## Abstract The human mast cell line (HMCโ€1^560^) was used to study the effects of tyrosine kinase (TyrK) inhibition on histamine release in consequence of intracellular Ca^2+^ or pH changes. This is important since the TyrK inhibitor STI571 (Glivecยฎ) inhibits proliferation and induces apoptosis in